









Markets
/
Stocks
/
nasdaq-ogn
/

Organon & Co

OGN

View Detailed Chart

9.750USD

+0.045+0.46%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

2.52BMarket Cap

3.35P/E TTM



Organon & Co

9.750

+0.045+0.46%

Overview Company Financials

Financials

Intraday

30m

Today

+0.46%

5 Days

-4.51%

1 Month

-2.11%

6 Months

-34.61%

Year to Date

-34.65%

1 Year

-53.37%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

HOLD

Current Rating

13.000

Target Price

33.33%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Organon & Co

OGN

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(3)

Buy(1)

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.007

Neutral

RSI(14)

47.324

Neutral

STOCH(KDJ)(9,3,3)

39.957

Sell

ATR(14)

0.311

Low Volatility

CCI(14)

-38.464

Neutral

Williams %R

64.646

Sell

TRIX(12,20)

0.060

Sell

StochRSI(14)

11.670

Oversold

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

9.920

Sell

MA10

9.925

Sell

MA20

9.844

Sell

MA50

9.716

Buy

MA100

10.942

Sell

MA200

13.340

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions. Its portfolio also includes VTAMA (tapinarof) cream, 1%, a nonbiologic, non-steroidal topical therapy, for treatment of mild, moderate, and severe plaque psoriasis in adults.

Ticker SymbolOGN

CompanyOrganon & Co

CEOMr. Kevin Ali

Websitehttps://www.organon.com/